E-CRRT Trial — Integration vs Separation of CRRT and ECMO Circuits

1. Publication

• Title: The comparison of circuit lifespan between integration and separation approach in extracorporeal membrane oxygenation patients requiring continuous renal replacement therapy support
• Acronym: E-CRRT Trial
• Year & Journal: Intensive Care Medicine, 2026;52:434-444
• Citation: Tangjitaree P, Thanapongsatorn P, Sinjira T, et al. The comparison of circuit lifespan between integration and separation approach in extracorporeal membrane oxygenation patients requiring continuous renal replacement therapy support: a randomized controlled trial (E-CRRT Trial). Intensive Care Med. 2026;52:434-444. doi:10.1007/s00134-026-08302-y

2. Context & Rationale

Background: ~50% of ECMO patients develop AKI requiring RRT (mainly CRRT). Two techniques combine CRRT with ECMO circuits — integration (CRRT circuit spliced into the ECMO circuit) and separation (independent CRRT circuit with dedicated vascular access) — but neither is considered a standard, guideline-endorsed approach; international recommendations deliberately avoid endorsing one technique due to limited comparative evidence.

Research Question/Hypothesis: In ECMO patients requiring CRRT, does the integration approach versus the separation approach affect CRRT circuit lifespan?

Why This Matters: Combined ECMO+CRRT is increasingly common, but the choice between techniques has practical implications for vascular access requirements, circuit complexity, and complication risk (bleeding, access-site issues) — a genuine, common bedside decision lacking comparative trial evidence until now.

3. Design & Methods

• Study Type: Multicenter randomized controlled trial
• Setting & Centers: King Chulalongkorn Memorial Hospital and Central Chest Institute of Thailand; conducted May 2021 – March 2025
• Population:
• Inclusion: Adult ECMO patients requiring CRRT support
• Exclusions: Not detailed in available trial text
• Intervention: Integration approach (CRRT circuit spliced into the ECMO circuit)
• Comparator: Separation approach (independent CRRT circuit with dedicated vascular access)
• Randomization: 1:1, 80 patients (40 integration, 40 separation)
• Blinding: Not detailed in available trial text (technique-based intervention, likely open-label given the visibly different circuit configurations)
• Statistical Power & Follow-Up: Primary outcome: CRRT circuit (filter) lifespan. Baseline characteristics (age, sex, illness severity, ECMO indication, AKI cause) were well balanced between groups.

4. Key Results

5. Internal Validity Assessment

• Randomization & Allocation: 1:1 randomization; specific concealment mechanics not detailed in available trial text.
• Protocol Adherence & Separation: Notable crossover asymmetry — 9/40 separation-arm patients crossed over (mainly due to unavailable/unsafe additional vascular access), versus 1/40 in the integration arm. This reflects a genuine, clinically relevant practical constraint of the separation technique rather than a trial-conduct flaw.
• Blinding & Detection Bias: Not detailed in available trial text; a technique-based intervention (visibly different circuit configurations) is inherently difficult to blind.
• Missing Data & Sensitivity Analyses: The null primary result was described as "robust across sensitivity analyses that accounted for clinically anticipated events, such as ECMO discontinuation, renal recovery, or death" per accompanying commentary.
• Overall Internal Validity Conclusion: Moderate — well-balanced baseline characteristics and sensitivity-analysis-robust null primary result support the finding, but the small sample size (80 patients) and asymmetric crossover (driven by real vascular-access constraints in the separation arm) are relevant limitations.

6. External Validity Assessment

• Population Representativeness: ECMO patients requiring CRRT at two Thai tertiary centers — a specific, resource-intensive combined-organ-support population.
• Practice Context: Both techniques require ECMO and CRRT capability and expertise; the separation approach specifically requires additional vascular access sites, which may be constrained in patients already requiring multiple lines/catheters (as reflected in the crossover pattern observed).
• Overall External Validity Conclusion: Moderate — directly informative for centers combining ECMO and CRRT, though single-country (Thailand), modest sample size, and specific local practice patterns may limit generalizability of exact effect estimates (though the qualitative "either technique is reasonable" conclusion likely generalizes well).

7. Strengths & Limitations

Strengths:

• First randomized comparison of two widely used but non-standardized techniques for combining CRRT and ECMO
• Sensitivity analyses robust to clinically anticipated competing events (ECMO discontinuation, renal recovery, death)
• Comprehensive safety outcome assessment (bleeding, hemolysis, bloodstream infection, air embolism, alarm burden)
• Directly informs a common, previously evidence-free bedside decision

Limitations:

• Small sample size (80 patients)
• Notable, asymmetric crossover (9 vs 1) reflecting practical vascular-access constraints specifically in the separation arm
• Two-center, single-country trial
• Blinding not clearly established for what is inherently a hard-to-blind technique-based intervention

8. Interpretation & Practice Impact

• Clinical Implications: Both integration and separation techniques for combining CRRT with ECMO appear equally effective (circuit lifespan) and safe (adverse events, mortality) — the choice can reasonably be guided by practical factors such as vascular access availability rather than a presumed superiority of either technique.
• Mechanistic Coherence: Higher access/return pressures in the integration group were an expected physical consequence of splicing into the ECMO circuit, but this did not translate into worse functional circuit outcomes — a reassuring dissociation between a measured physical parameter and actual clinical performance.
• Systems-Level Takeaway: Supports flexible, access-availability-driven protocol design for combined ECMO+CRRT programs rather than mandating a single institutional standard technique.

9. Controversies & Subsequent Evidence

• Editorial Commentary: An accompanying Intensive Care Medicine commentary ("CRRT and ECMO: one love or separate lives?") frames the trial's contribution against the backdrop of guidelines that have deliberately avoided endorsing a single technique, given previously limited comparative evidence — this trial now provides that missing head-to-head data.
• Guideline Integration: Not yet formally incorporated into major guidelines at time of this handbook's compilation, but directly addresses the evidence gap current guidelines had explicitly acknowledged.

10. Summary & Executive Takeaway

Summary: This Thai multicenter RCT randomized 80 ECMO patients requiring CRRT to integration or separation circuit configuration. Median CRRT circuit lifespan was not significantly different (72h vs 71h, P=0.52), nor was 28-day mortality (32.5% vs 35%, P=0.81) or serious adverse events. Crossover was more common in the separation arm (9 vs 1 patients), reflecting vascular-access constraints.

Overall Takeaway: Integration and separation approaches for combining CRRT with ECMO are equally effective and safe — technique choice can be guided by practical factors like vascular access availability rather than a presumed superiority of either method, filling a genuine, previously evidence-free gap in combined extracorporeal organ support practice.

11. Bibliography

• Ostermann M, Lumlertgul N. Acute kidney injury in ECMO patients. Crit Care. 2021;25:313.
• CRRT and ECMO: one love or separate lives? [editorial]. Intensive Care Med. 2026.